Insiders · Profile

Martin Michael Robert

Chief Business Officer at Aurinia Pharmaceuticals. Filing since 22 Jun 2021. CIK 0001837647

Company
Date
Role
Action
Shares
Amount
Of holding
7 Nov 2022
Chief Business Officer
Bought
30,000
$154.80K
50.4%
2 Mar 2022
Chief Business Officer
Sold, plan not stated
4,849
$58.24K
7.5%
11 Nov 2021
Chief Business Officer
Sold, plan not stated
40,000
$1.16M
41.7%
10 Nov 2021
Chief Business Officer
Sold, plan not stated
60,000
$1.87M
47.3%
9 Nov 2021
Chief Business Officer
Sold, plan not stated
50,000
$1.51M
28.3%
1 Nov 2021
Chief Business Officer
Sold, plan not stated
45,000
$1.42M
20.3%
21 Sep 2021
Chief Business Officer
Sold, plan not stated
87,500
$2.10M
33.1%
20 Sep 2021
Chief Business Officer
Sold, plan not stated
28,500
$616.98K
13.9%
14 Sep 2021
Chief Business Officer
Sold, plan not stated
134,000
$2.87M
43.1%
10 Sep 2021
Chief Business Officer
Sold, plan not stated
25,000
$495.00K
12.4%
7 Sep 2021
Chief Business Officer
Sold, plan not stated
7,500
$135.75K
4.1%
26 Aug 2021
Chief Business Officer
Sold, plan not stated
22,500
$400.73K
10.9%
9 Aug 2021
Chief Business Officer
Sold, plan not stated
5,000
$80.05K
2.4%
28 Jul 2021
Chief Business Officer
Sold, plan not stated
5,000
$69.30K
2.3%
22 Jun 2021
Chief Business Officer
Sold, plan not stated
5,000
$68.80K
2.3%
15 decisions on file.